A Study of Sublingual Immunotherapy in Peanut-allergic Children

Completed · Phase 2 · Has a placebo group

Conditions studied: Food Hypersensitivity

In brief

The specific aim of this study is to determine if peanut allergen-specific SLIT will cause clinical desensitization and tolerance to develop in peanut-allergic young children.

Key facts

Study ID

NCT00597727

Run by

University of North Carolina, Chapel Hill

People needed

60

Starts

2008-01-01

Expected to finish

2016-03-01

Last updated by the study team

2018-03-27

Who can join

Age: 1 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Peanut IgE > 7kU/L (> 2kU/L for children aged 2 years and under) AND
• History of significant clinical symptoms within 60 minutes after the ingestion of peanuts.

You may not qualify if…

• History of severe life-threatening anaphylaxis to peanut, OR
• Medical history that would prevent a DBPCFC to peanut, OR
• Subjects with wheat or oat allergy (which are used in the placebo), OR
• Unable to cooperate with challenge procedures, OR
• Unable to be reached by telephone for follow-up

Where it is running

• University of North Carolina — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.